
Yash starrer Toxic has surpassed all expectations in advance bookings! The gangster drama directed by Geetu Mohandas was enjoying massive pre-release buzz. But the momentum witnessed an unbelievable surge in the last 24 hours, as it has registered the 7th highest BMS pre-sales of all time. Scroll below for the latest box office updates!
Toxic sells over 1.6 million tickets in final BMS pre-sales
According to the final update, Toxic has sold a staggering 1.67 million tickets via advance booking on BMS. It witnessed an unbelievable response, selling 759K tickets during the final 24 hours. It has registered the second-highest ticket sales for a Kannada film, after Yash’s own KGF Chapter 2 (2.9 million).
Take a look at the detailed day-wise pre-sales of Toxic on BMS:
- Day 1 (August 21): 346.41K
- Day 2 (August 22): 175.47K
- Day 3 (August 23): 160.68K
- Day 4 (August 24): 228.48K
- Day 5 (August 25): 759K
Total: 1.67 million
6th highest pre-sales of all time on BookMyShow!
Kiara Advani co-starrer has surpassed every Indian release of 2026 to register the 2nd highest ticket sales. It is only behind Dhurandhar 2 (2.41 crore).
Trending
In terms of all-time highest BMS pre-sales (since the trending feature was introduced in August 2023), Toxic has registered the 7th spot. It has left behind Salaar (1.66 million), Jawan (1.65 million) and L2: Empuraan (1.33 million). The gangster drama missed surpassing Kalki 2898 AD (1.72 million) by a small margin.
Check out the top 10 final pre-sales of all time on BMS (since August, 2023):
- Pushpa 2: 3 million
- Coolie: 2.52 million
- Dhurandhar 2: 2.41 million
- Leo: 2.28 million
- Spider-Man: Brand New Day: 2 million
- Kalki 2898 AD: 1.72 million
- Toxic: 1.67 million
- Salaar: 1.66 million
- Jawan: 1.65 million
- L2: Empuraan: 1.33 million
Advertisement
Stay tuned to Koimoi for more box office updates!
Must Read: Irumudi Worldwide Box Office Day 4: Becomes Ravi Teja’s Solo Highest-Grossing Film, Beats Dhamaka
Follow Us: Facebook | Instagram | Twitter | YouTube | Google News

Join Us




